Would they not be able to profit from the stability of lab-produced drugs? Would the generic market not want to produce these? After all, some of the drug manufacturers produce both brand-name and generic drugs [1].
Regardless of patent, I'm pretty sure some players would happily get into the prescription market. On top of this, I'm going to guess since it seems some of these drugs out-perform the available prescription drugs and is cheaper in the long run, insurance companies and governments alike (since some places have universal care and even the US is invested in some forms of healthcare) stand to profit from having this sort of thing be the first line of treatment when possible.
[1] http://www.pharmaceutical-technology.com/features/featurethe...